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Purpose:  Genetic factors are known to be important in the 
etiology of bipolar disorder (BD). The fragile sites (FSs) are 
a very interesting subject for the study of clinical disorders. 
The aim of this study was to evaluate fragile sites seen in 
patients with bipolar disorder and find a correlation between 
some fragile sites and bipolar disorder. Patients and Methods: 
The frequencies of folate sensitive FSs were compared in short- 
term whole blood cultures from bipolar patients and from 
normal individuals. Results: The rate of FS expression in the 
patients was considerably higher than in the controls (p < 
0.001). Several chromosome regions including 1p36, 1q21, 
1q32, 3p25, 7q22, 7q32, 11q23, 12q24, 13q32, 14q24, Xp22 
and Xq26 were represented considerably more often in the 
patients than in the controls (p value between 0.001 to 0.036). 
Among these FSs, the sites 1p36, 1q21, 3p25, 7q22, 7q32, and 
14q24 were not observed in other studies. Conclusion: These 
regions can be the most active of hot spots in the genomes 
of bipolar patients, and may harbor important genes associated 
with BD.
Key Words: Bipolar disorder, cytogenetics, fragile sites, 
chromosome 1, 3, 7, 11, 12, 13, 14 and X 
INTRODUCTION
BD affects ~ 1% of the population and shows 
strong heritability. Cytogenetic studies in 
psychiatry are important in view of the potential 
multiple etiologies of psychiatric syndromes and 
due to the high incidence of chromosome abnor-
malities reported in diverse psychiatry. The folic 
acid sensitive FSs in normal and abnormal popu-
lations remain unknown. It has been previously 
determined that there is a possible relationship 
which connects schizophrenia and folate.
1 An 
analysis of FSs in bipolar and unaffected indi-
viduals showed a higher frequency of FSs at 1q32 
in the bipolar population compared to the 
frequency of FSs in the controls using low folate 
media.
2 Recent genetic studies have confirmed 
that susceptibility loci exist for BD on multiple 
regions of the human genome, including 4p14, 
4q35, 6q24, 10p13-12, 12q24, 13q32, 16p, 18p11.2, 
18q22, 20p11.2-q11.2, 21q21, 22q11-13, Xq, and 
Xq26.
3-8 This data suggests that some chromo-
somal regions may play an important role in the 
genetics of BD. 
In order to identify new or similar hot spots 
which are worthy of further study and that may 
be associated with BD, we reported our chromo-
somal findings from a control group of 40 patients 
with BD.
PATIENTS AND METHODS
A total of 40 patients who were diagnosed with 
BD [according to the DSM-IV criteria (American 
Psychiatric Association 1994)
9] were recruited for 
this cytogenetic study. The patient group consisted 
of 23 males and 17 females. Their ages ranged 
from 18 to 47 years with a mean age of 32.61 ± 
7.93 years. The patients were selected from a hos-
pital for psychiatric and neurological diseases 
located in Adana, Turkey between October 2000 
and December 2002. The study was granted 
ethical approval by the local health committee. Osman Demirhan, et al. 138
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The control group consisted of 34 healthy volun-
teers, 23 males and 11 females with a mean age 
of 37.13 ± 10.08 years.
Each sample was examined the for expression 
of folate-sensitive FS by the Faculty of Medicine 
in our Laboratory of Genetics at the Department 
of Medical Biology and Genetics, Çukurova Uni-
versity. The folate-sensitive FSs are likely to all be 
CCG repeat expansions similar to the fragile X. 
This is due to the abnormal expansion of genes 
with trinucleotide repeat polymorphisms, which 
have been found in bipolar affective disorder.
10 
These sites have longer, more complex repeat 
elements. Only two rare FSs (FRAXA and FRAXE) 
are of such unequivocal clinical significance that 
they are actually associated with intellectual dis-
ability.
11 Because of this, we used a folic acid-free 
medium (RPMI-1640, Sigma R6767 without folic 
acid) supplemented with 4% fetal calf serum, 
phytohemagglutinin, streptomycin, and penicillin. 
Standard cytogenetic techniques were used for 
harvesting and for slide preparation. Three slides 
were prepared for each subject. The slides were 
first stained only with Giemsa before examination 
in order to avoid the missing of any gaps. For 
detailed analysis of the FS, some slides were pre-
pared by trypsin G-banding and at least 50 meta-
phases were scored for each assay. All gaps and 
breaks were recorded and localized according to 
the ISCN (1985).
12 The classification of FS was done 
according to the nomenclature established in 
human gene mapping HGM 11.
13
A non-parametric Mann-Whitney test was used 
for the statistical comparison of the means of chro-
mosomal breaks and aberrant cells between patients 
and controls. The 
2 test was used to determine 
the difference in frequency of FSs observed between 
the patient and the control group.
RESULTS
A total of 2,033 cells from 40 patients with BD 
were analyzed for chromosomal FSs under treat-
ment with folic acid-free medium. A total of 1,245 
aberrations were found in 783 (38.5%) cells. In the 
control group, 297 aberrations were found in 262 
(13.1%) cells among 2,000 analyzed cells. There 
was a significant difference in the total number of 
FSs expressed between patients and controls by 
the  
2  test (p < 0.001). No age and sex effects on FS 
expression were evident in our patients.
The analysis of the distribution of FSs on chro-
mosomes showed that they were present in 1% of 
the cells analyzed and 15 of these different chro-
mosomal FSs in the patient group included 10 c- 
fra [1p36(FRA1A), 1q21(FRA1F), 1q32(unknown), 3p 
14(FRA3B), 5q31(FRA5C), 7q22(FRA7F), 7q32 (FRA 
7H), 13q32(FRA13D), 14q24(FRA14C), and Xp22 
(FRAXB)], 4 r-fra [11q23(FRA11B), 12q24(FRA 12D), 
16q22(FRA16C) and Xq26(unknown)], and 1 previ-
ously unknown folate sensitive FS [3p25 (un-
known)] (Table 1). Among these expressed FSs, 
there was a significantly higher frequency of 12 
FSs at 1p36, 1q21, 1q32, 3p25, 7q22, 7q32, 11q23, 
12q24, 13q23, 14q24, Xp22 and Xq26 in the patient 
group than in the controls, as determined by the 

2 test (p value between 0.001 to 0.036), excluding 
the 3p14, 5q31 and 16q22 regions (p value between 
0.092 to 1.000) (Table 1). 
DISCUSSION
Genetic factors are known to be important in 
the etiology of BD. The FS is a very interesting 
subject for the study of clinical disorders, because 
chromosomes have a tendency to break an FS, 
which can lead to the formation of deletions and 
translocations.
14 The incidence of the folic acid- 
sensitive FSs in the BD remains unknown. The 
linkage findings in BD can be obtained from the 
collection of cytogenetic studies. Chromosomal 
regions of interest include 13q32, 1q32, 18p11.2, 
Xq26.3-q28, 4p16, 12q23-q24, 16p13, 21q22, Xq24- 
q26, Xq26.
3,15,16 Our study represents the investiga-
tion of the possible involvement of chromosomal 
FSs in the etiology of BD.
In the present study, the frequency of FS was 
increased in lymphocyte cultures from patients 
with folate-sensitivity, which was significant when 
compared to the control group. It may be con-
sidered that the expression of c-fra could be an 
indicator of chromosomal instability. Of the 8 
common and 3 rare FSs found in our study, 2 
were listed in HGM11. 3p25 was neither in 
HGM11, nor reported previously. This site might 
be a novel folate-sensitive FS in BD. Of the FSs Cytogenetic Findings of Bipolar Patients 139
Yonsei Med J Vol. 50, No. 1, 2009
Table 1. Fragile Sites Frequency, Distribution, and Numbers of Patients and Controls with Expression of Fragilities 
at Different Sites in Bipolar and Controls
Fragile
 sites
Classification
Bipolar patients (n = 40) Controls (n = 34)
p value Total no. 
of FS 
observed
Population 
frequency 
of FS
Relative 
proportion 
of FS
Patients
(n)
Total no. 
of FS 
observed
Population 
frequency 
of FS
Relative 
proportion 
of FS
Controls
(n)
1p36 Common 24 1.18 1.92 14 2 0.11  0.67  2  0.004
1q21 Common  29 1.42 2.32 15 4 0.23  1.34  4  0.016
1q32 Common 25 1.22 2.00 15 5 0.29  1.68  2  0.002
3p14 Common 65 3.19 5.22 19 39 2.29 13.13 16  1.000*
3p25 Folate sensitive 32 1.57 2.57 14 3 0.17  1.01  3  0.011
5q31 Common 42 2.06 3.37 19 11 0.64  3.70  9  0.092*
7q22 Common 44 2.16 3.53 20 8 0.47  2.69  5  0.002
7q32 Common 30 1.47 2.40 17 6 0.35  2.02  6  0.025
11q23 Rare 29 1.42 2.32 15 5 0.29  1.68  5  0.036
12q24 Rare 26 1.27 2.08 14 3 0.17  1.01  3  0.011
13q32 Common 33 1.62 2.65 16 2 0.11  0.67  2  0.001
14q24 Common 22 1.08 1.76 18 6 0.35  2.02  5  0.006
16q22 Rare 19 0.93 1.52 11 9 0.52  3.03  6  0.409*
Xp22 Common 22 1.08 1.76 14 2 0.11  0.67  2  0.004
Xq26 Rare 21 1.03 1.68 12 1 0.05  0.33  1  0.002
Total 1,245 297
FS, fragile site.
*When the number of patients were compared with the controls, there was no significant differences (p >0 . 0 5 )
found in 33 cases (82.5%) out of 40 cases, c-fra at 
1p36, 1q21, 1q32, 7q22, 7q32, 13q23, 14q24 and 
Xp22, and c-fra were expressed most frequently 
(Table 1). These sites may be hot spots for BD. 
Specifically, in our study, 7q22 expression was 
observed the most frequently with an incidence of 
52%, followed by 7q32 (46%) (Table 1). A recent 
analysis has identified a locus on chromosome 7q 
for the language, and for repetitive or stereotyped 
behavior deficits.
17 The results of two earlier genome 
scans has provided evidence for the involvement 
of 7q22 in schizophrenia.
18,19 These independent 
results are consistent with the hypothesis related 
to susceptibility to BD.
We found three FSs on chromosome 1 at band 
1p36, 1q21, and 1q32 that were significantly over- 
expressed in BD compared with the incidence of 
expression in controls (p = 0.002 - 0.016). Previous 
works have indicated a higher frequency of FSs at 
1q32 in the bipolar patients when compared to 
controls.
2,16 Similarly, evidence suggesting linkage 
to schizophrenia at the 1q21 - 22 and 1q32 - 41 loci 
has also been provided independently by three 
groups.
20-22 It is interesting that the 1q21 site 
contains the locus of the dopamine receptor (DS) 
pseudogene I.
23 The 1p36 site in our patients is a 
new class of FS, which have previously been called 
viral modification sites.
24 
The 11q23 site was also significantly over-ex-
pressed in our patients compared to the normal 
controls (p = 0.036). Linkage has been reported 
between bipolar disorder and chromosome 11.
25-27 Osman Demirhan, et al. 140
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This rare FS was also observed in schizophrenic 
patients in another study.
20 Published results of 
linkage studies of bipolar disorder have focused 
on chromosome 12q, where bipolar disorder was 
initially found to associate with Darier's disease,
28 
and the results of two earlier genome scans has 
provided evidence for the involvement of the 
12q24 site for BD.
8,16 The 12q24 and 13q32 expres-
sion have been observed most frequently in our 
patients (Table 1). Similarly, the 13q32 site has 
been also reported in bipolar patients.
16,29
In our study, the X chromosome breaks and gaps 
were clearly clustered at Xp22 and Xq26. Linkage 
has been reported between bipolar disorder and 
loci on the X chromosome.
30,31 Many of the genes 
along the X chromosome are expressed in the brain. 
The X chromosome includes the locus for other 
X-linked mental retardation (XLMR) syndromes. 
Mutations in any of these genes, which are essen-
tial for normal brain development and function, 
are potential causes of these XLMRs. Several 
linkage studies have provided evidence for a 
susceptibility locus related to bipolar disorder on 
chromosome Xq24 - 26, Xq24 - q27.1, Xq24 - q28 
and Xq26.3 - 28.
3,8,29,32 The higher expression of FSs 
along with the X chromosome mutations observed 
in our patients can lead to a local block of several 
genes in the regions around the FSs, leading to a 
variety of behavior disturbance in individuals. 
The other chromosomal FSs at 1q21, 1q36, 3p25, 
7q22, 7q32 and 14q24 were observed most fre-
quently in bipolar patients in the present study. 
These FSs were not observed in other studies and 
may be new hot spots associated with BD.
In conclusion, it is still not clear whether an 
association between FS and BD can provide impor-
tant knowledge in the search for the chromosomal 
location of major genes. Our findings suggest that 
these interesting regions may harbor important 
genes for BD and lead to a variety of behavior 
disturbance in individuals.
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